Aesthetic Medical Reports H1 2025 Unaudited Financials
Ticker: PAIYY · Form: 6-K · Filed: Aug 19, 2025 · CIK: 1757143
Sentiment: neutral
Topics: financial-results, 6-K, unaudited
Related Tickers: PAIYY
TL;DR
PAIYY dropped H1 2025 unaudited results on 8/19. Check financials.
AI Summary
Aesthetic Medical International Holdings Group Limited (OTCQX: PAIYY) reported its unaudited financial results for the first half of 2025 on August 19, 2025. The company is based in Shenzhen, China, and operates in the specialty outpatient facilities sector.
Why It Matters
This filing provides investors with the latest financial performance data for Aesthetic Medical International Holdings Group, allowing them to assess the company's recent operational and financial health.
Risk Assessment
Risk Level: low — This is a routine financial results disclosure (6-K form) with no immediately apparent significant negative or positive events.
Key Players & Entities
- Aesthetic Medical International Holdings Group Limited (company) — Filer of the report
- PAIYY (company) — Ticker symbol for Aesthetic Medical International Holdings Group Limited
- August 19, 2025 (date) — Date of the report and announcement
- Shenzhen, China (location) — Company's principal executive offices
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K filing is to report the unaudited financial results of Aesthetic Medical International Holdings Group Limited for the first half of 2025.
When were the financial results announced?
The financial results were announced on August 19, 2025.
What is the company's stock ticker symbol?
The company's stock ticker symbol is PAIYY.
Where are Aesthetic Medical International Holdings Group Limited's principal executive offices located?
The company's principal executive offices are located at 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China.
Does the company file annual reports under Form 20-F or Form 40-F?
The company indicates it files annual reports under Form 20-F.
Filing Stats: 2,924 words · 12 min read · ~10 pages · Grade level 9.2 · Accepted 2025-08-19 16:02:17
Filing Documents
- tm2523740d1_6k.htm (6-K) — 213KB
- 0001104659-25-080247.txt ( ) — 214KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Aesthetic Medical International Holdings Group Limited By: /s/ Guanhua Wu Name: Guanhua Wu Title: Chief Financial Officer Date: August 19, 2025